DrugPatentWatch Database Preview

Details for Patent: 6,713,446

Which drugs does patent 6,713,446 protect, and when does it expire?

Patent 6,713,446 protects VELCADE and is included in one NDA.

Protection for VELCADE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has nineteen patent family members in twelve countries.

Summary for Patent: 6,713,446

Title:	Formulation of boronic acid compounds
Abstract:	The present invention provides stable compounds prepared from boronic acid and lyophilized compounds thereof of the formula (1): ##STR1## in which Z.sup.1 and Z.sup.2 are moieties derived from sugar. The invention also provides methods for preparing such compounds. Lyophilizing a mixture comprising a boronic acid compound and a moiety derived from sugar produces a stable composition that readily releases the boronic acid compound upon reconstitution in aqueous media.
Inventor(s):	Gupta; Shanker Lal (Rockville, MD)
Assignee:	The United States of America as represented by the Secretary of the Department of Health and Human Services (Washington, DC)
Application Number:	10/056,567
Patent Claim Types: see list of patent claims	Compound; Use; Composition;

Drugs Protected by US Patent 6,713,446

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Millennium Pharms	VELCADE	bortezomib	INJECTABLE;INTRAVENOUS, SUBCUTANEOUS	021602-001	May 13, 2003		RX	Yes	Yes	➤ Sign Up	➤ Sign Up			Y		➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Non-Orange Book US Patents Family Members for Patent 6,713,446

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
7,109,323	Formulation of boronic acid compounds	➤ Sign Up
6,699,835	Formulation of boronic acid compounds	➤ Sign Up
6,958,319	Formulation of boronic acid compounds	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Family Members for US Patent 6,713,446

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	501157	➤ Sign Up
Australia	2002243646	➤ Sign Up
Canada	2435124	➤ Sign Up
Canada	2435146	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 6,713,446

For more information try a trial or see the plans and pricing